PIAS3
E3 SUMO-protein ligase PIAS3
Also known as: FLJ14651, PIAS3_HUMAN, ZMIZ5
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9Y6X2
- Gene
- PIAS3
- Ensembl
- ENSG00000131788
- Chromosome
- 1
- Canonical length
- 628 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
This gene encodes a member of the PIAS [protein inhibitor of activated STAT (signal transducer and activator of transcription)] family of transcriptional modulators. The protein functions as a SUMO (small ubiquitin-like modifier)-E3 ligase which catalyzes the covalent attachment of a SUMO protein to specific target substrates. It directly binds to several transcription factors and either blocks or enhances their activity. Alternatively spliced transcript variants of this gene have been identified, but the full-length nature of some of these variants has not been determined. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
628 residues, UniProt reviewed canonical sequence.
>Q9Y6X2|PIAS3
1 MAELGELKHM VMSFRVSELQ VLLGFAGRNK SGRKHELLAK ALHLLKSSCA PSVQMKIKEL
61 YRRRFPRKTL GPSDLSLLSL PPGTSPVGSP GPLAPIPPTL LAPGTLLGPK REVDMHPPLP
121 QPVHPDVTMK PLPFYEVYGE LIRPTTLAST SSQRFEEAHF TFALTPQQVQ QILTSREVLP
181 GAKCDYTIQV QLRFCLCETS CPQEDYFPPN LFVKVNGKLC PLPGYLPPTK NGAEPKRPSR
241 PINITPLARL SATVPNTIVV NWSSEFGRNY SLSVYLVRQL TAGTLLQKLR AKGIRNPDHS
301 RALIKEKLTA DPDSEVATTS LRVSLMCPLG KMRLTVPCRA LTCAHLQSFD AALYLQMNEK
361 KPTWTCPVCD KKAPYESLII DGLFMEILSS CSDCDEIQFM EDGSWCPMKP KKEASEVCPP
421 PGYGLDGLQY SPVQGGDPSE NKKKVEVIDL TIESSSDEED LPPTKKHCSV TSAAIPALPG
481 SKGVLTSGHQ PSSVLRSPAM GTLGGDFLSS LPLHEYPPAF PLGADIQGLD LFSFLQTESQ
541 HYGPSVITSL DEQDALGHFF QYRGTPSHFL GPLAPTLGSS HCSATPAPPP GRVSSIVAPG
601 GALREGHGGP LPSGPSLTGC RSDIISLDLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PIAS3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.49
- Highest tissue expression
- 37 nTPM
Expression across tissuesHPA
Tissue
- blood vessel: 37 nTPM
- fallopian tube: 35 nTPM
- esophagus: 35 nTPM
- skin: 32 nTPM
- endometrium: 32 nTPM
- vagina: 32 nTPM
Single-cell type
- esophageal suprabasal cells: 51 nCPM
- fallopian tube ciliated cells: 51 nCPM
- esophageal apical cells: 41 nCPM
- respiratory ciliated cells: 38 nCPM
- endometrial ciliated cells: 36 nCPM
- retinal pigment epithelial cells: 30 nCPM
Immune cell
- NK-cell: 15 nTPM
- non-classical monocyte: 13 nTPM
- memory CD8 T-cell: 12 nTPM
- MAIT T-cell: 11 nTPM
- eosinophil: 11 nTPM
- gdT-cell: 11 nTPM
Brain region
- hypothalamus: 26 nTPM
- choroid plexus: 25 nTPM
- cerebral cortex: 25 nTPM
- midbrain: 23 nTPM
- thalamus: 22 nTPM
- medulla oblongata: 22 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about PIAS3.
Disease | ImmuneIEDB
Conditions an epitope on PIAS3 was assayed in.
- breast cancer T cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.3
- gnomAD pLI
- 0.98
- gnomAD missense Z
- 1
- DepMap mean gene effect
- -0.19
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 8% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- negative regulation of gene expression
- negative regulation of osteoclast differentiation
- negative regulation of protein sumoylation
- negative regulation of transcription by RNA polymerase II
- positive regulation of protein sumoylation
- protein sumoylation
- regulation of transcription by RNA polymerase II
- regulation of tumor necrosis factor-mediated signaling pathway
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PIAS3 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PIAS3 as an antibody target. Whether an autoantibody or antibody against PIAS3 could matter depends on whether native PIAS3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PIAS3 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PIAS3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...